Blue Gentian v. Tristar Products: XHose Patent Battle Settles After 12 Years
Blue Gentian LLC and National Express Inc. pursued Tristar Products Inc. and its principal Keith Mirchandani for alleged infringement of four US patents covering the iconic XHose expandable garden hose. Filed in New Jersey District Court in March 2013, the case ran for 4,578 days — over 12 years — before the parties reached a settlement in October 2025.
A 12-year XHose patent war ends at the settlement table
In March 2013, Blue Gentian LLC and its licensing partner National Express Inc. filed suit in the United States District Court for the District of New Jersey against Tristar Products Inc. and company principal Keith Mirchandani. The complaint alleged infringement of four US patents — US8291942B2, US8757213B2, US8291941B1, and US8479776B2 — all directed to the expandable hose technology commercialised as the XHose® product, a consumer gardening product that contracts and expands under water pressure.
On October 2, 2025, the court entered an administrative termination order after the parties reported a settlement, ending the litigation without a merits ruling. The order is not a dismissal under the Federal Rules of Civil Procedure; the parties have 60 days to file formal dismissal papers or, if the settlement cannot be consummated, to request the case be reopened. Absent such filing, the court will dismiss with prejudice and without costs — a standard mechanism preserving finality while allowing time for settlement documentation.
A resolution timeline exceeding 12 years is highly atypical even for complex multi-patent consumer product disputes, suggesting the case encountered significant procedural complexity, inter partes review proceedings, or protracted licensing negotiations. The specific financial terms, royalty arrangements, or licence scope remain confidential and are not reflected in the public record. Whether Tristar obtained an ongoing licence or agreed to cease use of the patented technology is unknown from the docket.
Filing to Case Settled in 4578 days
4,578 days — among the longest-running consumer product patent disputes in D.N.J. history
Case settles after 12 years: what the resolution means for both sides
Administrative termination — not yet a final dismissal
The October 2, 2025 order administratively terminates the action but expressly states it does not constitute a dismissal under the Federal Rules of Civil Procedure. The parties must file formal dismissal papers within 60 days. If they fail to do so, the court will dismiss with prejudice and without costs automatically. This two-step process is standard in D.N.J. and preserves the court’s docket while giving parties time to execute settlement agreements.
Administrative terminationSettlement avoids invalidity risk on a 12-year-old patent portfolio
Blue Gentian and National Express secured a negotiated resolution without subjecting their four XHose patents to a final merits ruling, preserving the patents’ enforceability on the public record. After more than a decade of litigation — during which patent validity could have been challenged in IPR proceedings — a settlement suggests the patent holder retained sufficient leverage to extract commercial value. The confidential terms likely include financial compensation and possibly a licensing arrangement or covenant not to sue.
Patents survive unchallenged by courtTristar avoids an adverse infringement judgment after prolonged exposure
Tristar Products and Keith Mirchandani avoided a court finding of infringement, which would have carried risks of enhanced damages and potential injunctive relief. However, 12 years of litigation represents substantial legal expenditure. Settlement at this late stage — after the case likely survived multiple dispositive motions — typically signals the defendant acknowledged some commercial risk of an adverse ruling. The absence of a costs award suggests the settlement was structured to give both sides a clean exit.
No infringement finding on recordXHose IP landscape remains privately resolved — not publicly adjudicated
Because the case settled without a merits ruling, the four XHose patents remain presumptively valid and have not been judicially construed or invalidated. Competitors and new market entrants in the expandable garden hose category cannot rely on this litigation as a source of claim construction guidance or invalidity findings. Anyone designing around or challenging these patents must treat them at full strength. The settlement also signals that Blue Gentian continues to actively enforce its IP in this consumer product space.
Patents enforceable; no claim construction issuedFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Blue Gentian, LLC | Company | Expandable hose IP licensor — holder of US8291942B2 and three related XHose patentsSearch in Eureka ↗ |
| Co-Plaintiff | National Express, Inc. | Company | Search in Eureka ↗ |
| Defendant | Tristar Products, Inc. | Company | Tristar Products Inc., consumer products marketer, and Keith Mirchandani, company principalSearch in Eureka ↗ |
| Co-Defendant | Keith Mirchandani | Individual | Search in Eureka ↗ |
| Plaintiff counsel | George C. Jones | Attorney | Counsel for Blue Gentian, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Gregory S. Gewirtz | Attorney | Counsel for Blue Gentian, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Kathleen N. Fennelly | Attorney | Counsel for Blue Gentian, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Robert B. Hander | Attorney | Counsel for Blue Gentian, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Thomas R. Curtin | Attorney | Counsel for Blue Gentian, LLCSearch in Eureka ↗ |
| Plaintiff law firm | GLENMARK PHARMACEUTICALS INC. USA | Law Firm | Representing Blue Gentian, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Lerner David, LLP | Law Firm | Representing Blue Gentian, LLCSearch in Eureka ↗ |
| Plaintiff law firm | McElroy, Deutsch, Mulvaney & Carpenter LLP | Law Firm | Representing Blue Gentian, LLCSearch in Eureka ↗ |
| Defendant counsel | Edward Paul Bakos | Attorney | Counsel for Tristar Products, Inc.Search in Eureka ↗ |
| Defendant counsel | J. BRUGH LOWER | Attorney | Counsel for Tristar Products, Inc.Search in Eureka ↗ |
| Defendant counsel | KATHERINE ST. ROMAIN | Attorney | Counsel for Tristar Products, Inc.Search in Eureka ↗ |
| Defendant counsel | Noam Joseph Kritzer | Attorney | Counsel for Tristar Products, Inc.Search in Eureka ↗ |
| Defendant counsel | RAVIPAL SINGH | Attorney | Counsel for Tristar Products, Inc.Search in Eureka ↗ |
| Defendant law firm | Bakos Law | Law Firm | Representing Tristar Products, Inc.Search in Eureka ↗ |
| Defendant law firm | FRIED FRANK HARRIS SHRIVER & JACOBSON LLP | Law Firm | Representing Tristar Products, Inc.Search in Eureka ↗ |
| Defendant law firm | Gibbons PC | Law Firm | Representing Tristar Products, Inc.Search in Eureka ↗ |
| Defendant law firm | Kritzer Mcphee LLP | Law Firm | Representing Tristar Products, Inc.Search in Eureka ↗ |
| Presiding judge | Judge N/A | Judge | New Jersey District CourtSearch in Eureka ↗ |
Official order — verbatim text
The October 2025 order reflects a court-supervised settlement mechanism commonly used in D.N.J.: the action is administratively closed rather than formally dismissed, preserving the ability to reopen if the deal falls through. The phrase ‘this shall not constitute a dismissal Order’ is significant — it means no res judicata or collateral estoppel attaches yet. Only once formal Rule 41 dismissal papers are filed will the case achieve true finality. The default backstop — dismissal with prejudice and without costs — protects both parties by ensuring eventual closure even if documentation is delayed.
US8291942B2 — XHose expandable garden hose technology
The four asserted patents — US8291942B2, US8757213B2, US8291941B1, and US8479776B2 — cover the expandable garden hose technology marketed as XHose®. Filed across application numbers US13/488515, US13/859511, US13/289447, and US13/690670, these patents protect the core innovation of a hose that expands under water pressure and contracts back to a compact size when flow ceases. The technology relies on an elastic inner tube housed within a flexible outer casing, enabling dramatic length expansion without kinking.
The XHose patents represent foundational IP in the fast-growing expandable garden hose consumer category, which attracted numerous competing products following the original product launch. Blue Gentian’s decision to assert all four patents simultaneously reflects a layered enforcement strategy designed to capture the full scope of the innovation across different claim sets — structural, method, and assembly claims. For manufacturers and retailers of collapsible or expandable fluid conduit products, this portfolio represents a significant freedom-to-operate risk that the 2025 settlement has not resolved or narrowed.
Should you run an FTO against US8291942B2 and the XHose patent family?
Any company developing, importing, distributing, or retailing expandable or self-contracting garden hoses in the US market should treat this four-patent portfolio as a live risk. The case settled without any judicial claim construction, invalidity ruling, or narrowing of the patent scope — leaving the patents at full presumptive validity. The XHose category is heavily competitive, and Blue Gentian’s demonstrated willingness to litigate for over a decade signals ongoing enforcement intent.
PatSnap Eureka’s FTO Search Agent can map your product architecture against the claim sets of US8291942B2, US8757213B2, US8291941B1, and US8479776B2, identify continuation and divisional descendants from the same application families, and surface any post-grant proceedings that may have narrowed claim scope. Eureka can also track Blue Gentian’s broader prosecution and enforcement activity, giving your IP and product teams early warning of new assertion risks before market launch.
Run a freedom-to-operate analysis on US8291942B2 to assess your product’s exposure
Run FTO in Eureka →Similar expandable hose and consumer product patent cases in D.N.J.
Explore related patent infringement actions in the D.N.J. involving expandable garden hose technology, consumer product IP, and multi-patent portfolio enforcement strategies.
What this case signals for the expandable hose IP landscape
A 12-year enforcement campaign across four patents signals the XHose IP portfolio remains commercially significant and actively defended.
Multi-patent portfolios dramatically extend litigation leverage
Blue Gentian asserted four separate US patents covering XHose technology. Defendants facing a multi-patent assertion must mount challenges on multiple fronts simultaneously — in district court and potentially through IPR at the USPTO. This structural complexity contributed to the case’s extraordinary duration and likely raised the cost of resistance for Tristar, ultimately driving the settlement.
Settlement without merits ruling keeps the patent portfolio fully loaded
No claim construction order, no invalidity finding, and no infringement ruling emerged from this 12-year proceeding. For companies operating in the expandable hose or collapsible fluid conduit space, these four patents remain fully enforceable threats. Freedom-to-operate clearance against US8291942B2, US8757213B2, US8291941B1, and US8479776B2 remains essential before entering this product category.
Blue v Tristar — key questions answered
Blue Gentian LLC and National Express Inc. asserted four US patents: US8291942B2 (App. No. US13/488515), US8757213B2 (App. No. US13/859511), US8291941B1 (App. No. US13/289447), and US8479776B2 (App. No. US13/690670). All four patents cover aspects of the XHose® expandable garden hose technology, involving inner elastic tube and outer casing constructions that expand under water pressure and retract when flow ceases.
The case was resolved by settlement. On October 2, 2025, the New Jersey District Court entered an administrative termination order after the parties reported the case had settled. The order is not a final dismissal under the Federal Rules; the parties have 60 days to file formal dismissal papers. If no papers are filed, the court will dismiss with prejudice and without costs by default. Financial terms are confidential and not reflected in the public record.
The case ran for 4,578 days from March 2013 to October 2025 — an exceptionally long duration even for complex patent litigation. The public record does not specify the exact causes, but cases of this length typically involve inter partes review proceedings at the USPTO challenging patent validity, multiple rounds of claim construction briefing, appellate proceedings, and extended settlement negotiations. The involvement of four separate patents also significantly increases litigation complexity.
No. A settlement without a merits ruling does not affect the legal validity of the asserted patents. US8291942B2, US8757213B2, US8291941B1, and US8479776B2 remain presumptively valid and fully enforceable against third parties. No court issued any invalidity finding, claim construction order, or judgment limiting the patents’ scope. Competitors in the expandable hose category cannot rely on this settlement as a defence against future infringement claims.
The public record does not disclose the specific allegations against Keith Mirchandani individually. However, naming a company principal as a co-defendant in patent infringement actions is a recognised litigation strategy typically used to assert personal liability for induced or wilful infringement, to prevent a company from shielding assets behind its corporate structure, and to increase settlement pressure. The inclusion of an individual defendant alongside a corporate entity is consistent with a deliberate enforcement strategy by the plaintiff.
PatSnap Eureka searches patents and litigation data to answer instantly.